Ignite Creation Date:
2024-05-05 @ 11:38 AM
Last Modification Date:
2024-10-26 @ 9:10 AM
Study NCT ID:
NCT00093821
Status:
COMPLETED
Last Update Posted:
2013-06-04
First Post:
2004-10-06
Brief Title:
Tanespimycin in Treating Young Patients With Recurrent or Refractory Leukemia or Solid Tumors
Sponsor:
National Cancer Institute NCI
Organization:
National Cancer Institute NCI
Conditions & Keywords Data
Conditions:
| Name |
|---|
| Recurrent Osteosarcoma |
| Childhood Chronic Myelogenous Leukemia |
| Childhood Desmoplastic Small Round Cell Tumor |
| Disseminated Neuroblastoma |
| Metastatic Childhood Soft Tissue Sarcoma |
| Metastatic Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor |
| Metastatic Osteosarcoma |
| Previously Treated Childhood Rhabdomyosarcoma |
| Recurrent Childhood Acute Lymphoblastic Leukemia |
| Recurrent Childhood Acute Myeloid Leukemia |
| Recurrent Childhood Rhabdomyosarcoma |
| Recurrent Childhood Soft Tissue Sarcoma |
| Recurrent Ewing SarcomaPeripheral Primitive Neuroectodermal Tumor |
| Recurrent Neuroblastoma |
Keywords: